Change from subcutaneous to intravenous abatacept and back in patients with rheumatoid arthritis as simulation of a vacation: a prospective phase IV, open-label trial (A-BREAK)

por Mueller, Ruediger B., Gengenbacher, Michael, Richter, Symi, Dudler, Jean, Möller, Burkhard, von Kempis, Johannes
Publicado 2016